Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Blood Advances|September 23, 2018
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative GroupTao Wu, Yong Yang, Su-Yu Zhu, et al.
Radiation Oncology (London, England)|November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark caseYu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
Microbiology Spectrum|August 2, 2022
Virome of Giant Panda-Infesting Ticks Reveals Novel Bunyaviruses and Other Viruses That Are Genetically Close to Those from Giant PandasRui Ma, Min Zhao, Haoning Wang, et al.
Frontiers in Endocrinology|March 3, 2020
Can Dietary Intake of Vitamin C-Oriented Foods Reduce the Risk of Osteoporosis, Fracture, and BMD Loss? Systematic Review With Meta-Analyses of Recent StudiesLing-Feng Zeng, Ming-Hui Luo, Gui-Hong Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapyDan-Qiong Wang, Lei Yan, Hong-Fen Wu, et al.
Cancer Reports (Hoboken, N.J.)|March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphomaJia-Xin Liu, Xin Liu, Yong Yang, et al.
JCO Global Oncology|January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness AnalysisJing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Blood Advances|July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCGShu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Leukemia|September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) studyYong Yang, Ying Wang, Xin Liu, et al.
Ejhaem|February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group databaseXuan Zheng, Bao-Lin Qu, Xin Liu, et al.
Pageof 31